|
|
xvii | |
|
|
xxi | |
|
Part I Progress of Biomedical Technologies and Ethics |
|
|
|
Section A Regenerative Medicine |
|
|
|
1.1 Primary Topic Article: The Ethics of Regenerative Medicine: Broadening the Scope beyond the Moral Status of Embryos |
|
|
5 | (22) |
|
|
|
1.2 Commentary: Stem Cell Clinical Research: The Biology Determines the Ethics |
|
|
27 | (4) |
|
|
1.3 Commentary: Regenerative Medicine and Science Literacy |
|
|
31 | (4) |
|
|
1.4 Commentary: Regenerative Medicine, Politics, and the High Price of Moral Constraint |
|
|
35 | (5) |
|
|
|
1.5 Response to Commentaries |
|
|
40 | (6) |
|
|
|
2.1 Primary Topic Article: Neural Repair as a Case Study in Neuroethics |
|
|
46 | (19) |
|
|
2.2 Commentary: Some Issues in Neuroethics |
|
|
65 | (4) |
|
|
|
2.3 Commentary: Public Participation as a Potential Counter Strategy against Unethical Optimism |
|
|
69 | (6) |
|
|
|
|
2.4 Commentary: Three Problems with Treatments for Parkinson's Disease |
|
|
75 | (5) |
|
|
2.5 Response to Commentaries: The Optimism of Misguided Ventures in Repairing the Brain |
|
|
80 | (11) |
|
|
|
|
3.1 Primary Topic Article: Autonomy and the Ethics of Biological Behaviour Modification |
|
|
91 | (22) |
|
|
|
|
3.2 Commentary: (Im)Moral Technology? Thought Experiments and the Future of `Mind Control' |
|
|
113 | (7) |
|
|
3.3 Commentary: Some Remarks on Moral Bioenhancement |
|
|
120 | (6) |
|
|
3.4 Commentary: Moral Technology and the Concept of `the Self' |
|
|
126 | (5) |
|
|
|
3.5 Response to Commentaries |
|
|
131 | (8) |
|
|
|
|
4.1 Primary Topic Article: Ethics, Eugenics, and Politics |
|
|
139 | (15) |
|
|
4.2 Commentary: Eugenics in Society: A Sociological and Historical Consideration |
|
|
154 | (5) |
|
|
4.3 Commentary: Are `Brave' Parents Practicing Eugenics, Enhancement, or Something Else? |
|
|
159 | (4) |
|
|
4.4 Commentary: Therapy, Enhancement, and Eugenics |
|
|
163 | (7) |
|
|
4.5 Commentary: The Nature of the Moral Obligation to Select the Best Children |
|
|
170 | (13) |
|
|
4.6 Response to Commentaries: The Real Force of `Procreative Beneficence' |
|
|
183 | (10) |
|
|
5.1 Primary Topic Article: The Misguided Quest for the Ethics of Enhancement |
|
|
193 | (12) |
|
|
5.2 Commentary: Thomas Murray's Enhancement of a Bioethics of Enhancement |
|
|
205 | (6) |
|
|
5.3 Commentary: Arguments for and against Enhancement in Sports |
|
|
211 | (7) |
|
|
5.4 Commentary: What We Can---and Cannot---Learn about the Ethics of Enhancement by Thinking about Sport |
|
|
218 | (6) |
|
|
5.5 Response to Commentaries: Laments, Limits, and Liberalism |
|
|
224 | (11) |
|
|
|
Section C Emerging Problems in Research Ethics |
|
|
|
6.1 Primary Topic Article: Redefining Property in Human Body Parts: An Ethical Enquiry |
|
|
235 | (29) |
|
|
6.2 Commentary: But Which Body: Body of Labor, or Body of Anatomy? |
|
|
264 | (4) |
|
|
6.3 Commentary: The Non-Ownership Thesis: A German Perspective |
|
|
268 | (7) |
|
|
6.4 Commentary: Legal Status of the Human Body and Tissues |
|
|
275 | (3) |
|
|
6.5 Response to Commentaries: Does `Dignity in Property' Tell Us Anything about Dignity and Bioethics? |
|
|
278 | (6) |
|
|
7.1 Primary Topic Article: Genetic Research to Facilitate Personalized Medicine: Ethical and Policy Challenges |
|
|
284 | (8) |
|
|
7.2 Commentary: Genetic Information: Direct to Consumers or Gatekeeping? |
|
|
292 | (3) |
|
|
7.3 Commentary: The Ethical and Social Aspects of Genetic Information and Personalized Medical Genomics |
|
|
295 | (3) |
|
|
7.4 Commentary: Gatekeeping Access to Genetic Information: A Response to "Genetic Research to Facilitate Personalized Medicine: Ethical and Policy Challenges" |
|
|
298 | (3) |
|
|
7.5 Response to Commentaries |
|
|
301 | (3) |
|
|
8.1 Primary Topic Article: Ethics in Emerging Forms of Global Health Research Collaboration |
|
|
304 | (14) |
|
|
8.2 Commentary: Reconciliation between Universality and Diversity |
|
|
318 | (5) |
|
|
8.3 Commentary: Research Ethics Governance in Korea: How and Why Does a Nation Adopt an Ethical Perspective into Research Oversight? |
|
|
323 | (6) |
|
|
8.4 Response to Commentaries: Some Reflections |
|
|
329 | (6) |
|
|
Section D Synthetic Biology and Chimera |
|
|
|
9.1 Primary Topic Article: The Ethical Issues of Synthetic Biology |
|
|
335 | (10) |
|
|
9.2 Commentary: Synthetic Biology, Intellectual Property, and Buddhism |
|
|
345 | (5) |
|
|
9.3 Commentary: Before the Dawn of Ethics in Synthetic Biology |
|
|
350 | (4) |
|
|
9.4 Response to Commentaries |
|
|
354 | (4) |
|
|
10.1 Primary Topic Article: Why Would It Be Morally Wrong to Create a Human-Animal Chimera? |
|
|
358 | (8) |
|
|
10.2 Commentary: In Defence of Repugnance |
|
|
366 | (5) |
|
|
10.3 Commentary: On Crossing the Line between Human and Nonhuman: Human Dignity Reconsidered |
|
|
371 | (6) |
|
|
10.4 Response to Commentaries |
|
|
377 | (3) |
|
|
11.1 Primary Topic Article: Chimera in Bioethics and Biopolitics |
|
|
380 | (10) |
|
|
11.2 Commentary: The Question of the Family in the Biopolitics of Chimeras |
|
|
390 | (4) |
|
|
11.3 Commentary: The Biopolitics and Bioethics Surrounding Chimeric Embryo Research in Japan: A Comment on Jonathan Moreno's "Chimera in Bioethics and Biopolitics" |
|
|
394 | (5) |
|
|
|
11.4 Response to Commentaries |
|
|
399 | (8) |
|
|
Part II Globalization and Bioethics |
|
|
|
Section A Organ Transplant |
|
|
|
12.1 Primary Topic Article: Trafficking and Markets in Kidneys: Two Poor Solutions to a Pressing Problem |
|
|
407 | (10) |
|
|
12.2 Commentary: Against Organ Markets but Be Cautious in Adopting Presumed Consent |
|
|
417 | (4) |
|
|
12.3 Commentary: Can a Presumed Consent System Stop Organ Trafficking? |
|
|
421 | (5) |
|
|
12.4 Commentary: Presuming Minor Consent and Allowing Family Veto: Two Moral Concerns about Organ Procurement Policy |
|
|
426 | (9) |
|
|
12.5 Commentary: Organ Donation and Social Amelioration: A Two-Pronged Approach to Organ Trafficking |
|
|
435 | (9) |
|
|
|
12.6 Response to Commentaries |
|
|
444 | (5) |
|
|
13.1 Primary Topic Article: Ethics Without Borders? Why the United States Needs an International Dialogue on Living Organ Donation |
|
|
449 | (12) |
|
|
|
|
|
|
|
13.2 Commentary: Can Living Donation Be Justified? |
|
|
461 | (7) |
|
|
|
13.3 Commentary: Living Organ Donation and Organ Shortages: Another Perspective |
|
|
468 | (6) |
|
|
13.4 Commentary: The Paradigm of Living Related Donation: Stretched, Strained, and Abused? |
|
|
474 | (9) |
|
|
13.5 Response to Commentaries |
|
|
483 | (5) |
|
|
|
|
|
14.1 Primary Topic Article: The Future of Altruistic Medicine |
|
|
488 | (15) |
|
|
14.2 Commentary: Local and Global Contexts of the Praxis of Bioethics: `Transplant Tourism' and `Altruistic' Medicine |
|
|
503 | (3) |
|
|
14.3 Commentary: Altruism in the Service of the Market and the State, and the Ethics of Regulation |
|
|
506 | (5) |
|
|
14.4 Commentary: Altruism in Organ Donation: Would Reciprocity Offer an Alternative Explanation? |
|
|
511 | (5) |
|
|
14.5 Commentary: A New Twist on Altruism: Survivors of Japan's 3/11 |
|
|
516 | (6) |
|
|
14.6 Response to Commentaries |
|
|
522 | (7) |
|
|
Section B Public Health Ethics |
|
|
|
15.1 Primary Topic Article: What is `Public Health Ethics'? |
|
|
529 | (10) |
|
|
15.2 Commentary: What is `Substantive Public Health Ethics'? |
|
|
539 | (4) |
|
|
15.3 Commentary: What are Collective Values? |
|
|
543 | (3) |
|
|
15.4 Commentary: What is Expected of Public Health Ethics? |
|
|
546 | (4) |
|
|
15.5 Commentary: Public Health as Civic Practice |
|
|
550 | (4) |
|
|
15.6 Response to Commentaries: In Defence of Substantive Public Health Ethics |
|
|
554 | (4) |
|
|
16.1 Primary Topic Article: Accountability for Reasonable Priority Setting |
|
|
558 | (13) |
|
|
|
16.2 Commentary: Reasonableness and Politics |
|
|
571 | (4) |
|
|
16.3 Commentary: Deliberation, Fair Outcome, and Empirical Evidence: An Analogy with Archives |
|
|
575 | (4) |
|
|
16.4 Commentary: Justice, Fairness, and Deliberative Democracy in Health Care |
|
|
579 | (7) |
|
|
16.5 Commentary: How to Combine Universal and Particular Elements in the Distributive Process |
|
|
586 | (4) |
|
|
16.6 Response to Commentaries: Further Thoughts on Implementing Accountability for Reasonableness |
|
|
590 | (5) |
|
|
|
Section C Care in the Aging Society |
|
|
|
17.1 Primary Topic Article: Taking Seriously Ill People Seriously: Ethics and Policy Dimensions of the Chronic Disease/End-of-Life Care Continuum |
|
|
595 | (15) |
|
|
|
17.2 Commentary: End-of-Life Care in Korea: The Tradition of Filial Loyalty in the Area of High-Tech Medicine |
|
|
610 | (4) |
|
|
17.3 Commentary: Chronic Disease and Mental Care |
|
|
614 | (4) |
|
|
17.4 Commentary: Navigating the Twilight Zone |
|
|
618 | (6) |
|
|
17.5 Response to Commentaries |
|
|
624 | (4) |
|
|
|
18.1 Primary Topic Article: Ethics in Long-Term Care Practice: A Global Call to Arms |
|
|
628 | (16) |
|
|
|
18.2 Commentary: Ethical and Policy Issues in Long-Term Care in China |
|
|
644 | (6) |
|
|
18.3 Commentary: Whose Rights? Rights Protection in Long-Term Care |
|
|
650 | (4) |
|
|
18.4 Commentary: Listening to Voices that Are Difficult to Hear |
|
|
654 | (2) |
|
|
18.5 Commentary: On Universal and Particular: Guidance Seeking via Human Rights and Ethics Facilitating |
|
|
656 | (6) |
|
|
18.6 Response to Commentaries |
|
|
662 | (7) |
|
|
|
Section D Rethinking Medical Professionalism |
|
|
|
19.1 Primary Topic Article: A Virtue Ethics Analysis of Disclosure Requirements and Financial Incentives as Responses to Conflicts of Interest in Physician Prescribing |
|
|
669 | (9) |
|
|
19.2 Commentary: Trust and Professionalism: A Perspective on Conflict of Interest Policy |
|
|
678 | (5) |
|
|
19.3 Commentary: Conflicts of Interest: Relationship between Japanese Physicians and the Pharmaceutical Industry |
|
|
683 | (5) |
|
|
19.4 Commentary: Virtue Ethics and Conflict of Interest |
|
|
688 | (5) |
|
|
19.5 Commentary: Dealing with Conflicts of Interest: Is Virtue Ethics Tough Enough? |
|
|
693 | (4) |
|
|
19.6 Response to Commentaries: Sketch of a Virtue Ethics Regulatory Model |
|
|
697 | (6) |
|
|
20.1 Primary Topic Article: The Future of Clinical Ethics Education: Value Pluralism, Communication, and Mediation |
|
|
703 | (9) |
|
|
|
20.2 Commentary: Barriers to Clinical Ethics Mediation in Contemporary Japan |
|
|
712 | (6) |
|
|
|
20.3 Commentary: Clinical Ethics After Morality: Mediation as Pure Procedure |
|
|
718 | (3) |
|
H. Tristram Engelhardt, Jr. |
|
|
20.4 Commentary: Bioethics Mediation and Narrative Consultation |
|
|
721 | (6) |
|
|
20.5 Commentary: The Functions and Limitations of Clinical Ethics Mediation |
|
|
727 | (3) |
|
|
20.6 Response to Commentaries |
|
|
730 | (5) |
|
|
|
21.1 Primary Topic Article: Informed Consent Revisited: A Global Perspective |
|
|
735 | (15) |
|
|
|
21.2 Commentary: Medical Practice and Cultural Myth |
|
|
750 | (7) |
|
|
21.3 Commentary: Whose Interest Is It Anyway? Autonomy and Family-Facilitated Approach to Decision-Making |
|
|
757 | (5) |
|
|
21.4 Commentary: How Should We Defend a Family-Based Approach to Informed Consent? |
|
|
762 | (4) |
|
|
21.5 Response to Commentaries: Informed Consent, Family, and Autonomy |
|
|
766 | (9) |
|
|
Index |
|
775 | |